Mettler-Toledo International, Inc. (NYSE:MTD - Get Free Report) has been given an average recommendation of "Hold" by the eleven analysts that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $1,280.90.
MTD has been the subject of several research reports. Citigroup raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a research note on Monday, April 7th. Bank of America lifted their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. Wells Fargo & Company lifted their target price on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research note on Monday, May 5th. Robert W. Baird lowered their target price on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research note on Tuesday, April 22nd. Finally, UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their target price for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th.
Get Our Latest Report on Mettler-Toledo International
Mettler-Toledo International Price Performance
Shares of MTD traded down $12.63 during mid-day trading on Wednesday, reaching $1,223.62. The company had a trading volume of 118,779 shares, compared to its average volume of 150,546. Mettler-Toledo International has a twelve month low of $946.69 and a twelve month high of $1,546.93. The company's 50-day moving average is $1,165.26 and its 200-day moving average is $1,195.64. The company has a market capitalization of $25.43 billion, a P/E ratio of 30.51, a P/E/G ratio of 3.76 and a beta of 1.37.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The business had revenue of $883.74 million during the quarter, compared to analysts' expectations of $876.61 million. During the same period in the prior year, the firm posted $8.89 EPS. Mettler-Toledo International's quarterly revenue was down 4.6% compared to the same quarter last year. As a group, equities analysts expect that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.
Insider Transactions at Mettler-Toledo International
In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the business's stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the transaction, the director directly owned 120 shares of the company's stock, valued at approximately $139,191.60. The trade was a 89.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.94% of the company's stock.
Institutional Trading of Mettler-Toledo International
Institutional investors have recently modified their holdings of the company. SBI Securities Co. Ltd. bought a new stake in shares of Mettler-Toledo International in the fourth quarter valued at about $33,000. WPG Advisers LLC bought a new stake in shares of Mettler-Toledo International in the first quarter valued at about $41,000. Zions Bancorporation National Association UT bought a new stake in shares of Mettler-Toledo International in the first quarter valued at about $43,000. Edmond DE Rothschild Holding S.A. bought a new stake in shares of Mettler-Toledo International in the fourth quarter valued at about $44,000. Finally, Golden State Wealth Management LLC lifted its holdings in shares of Mettler-Toledo International by 583.3% in the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock valued at $48,000 after purchasing an additional 35 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.
About Mettler-Toledo International
(
Get Free ReportMettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Read More

Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.